UNICREDIT BANK/CALL/BIOGEN IDEC/320/0.1/15.01.25 Share Price

Warrant

DE000HD31TJ0

Market Closed - BOERSE MUENCHEN 01:11:55 18/05/2024 am IST
0.56 EUR +16.67% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/320/0.1/15.01.25
Current month+80.65%
1 month+211.11%
Date Price Change
17/24/17 0.56 +16.67%
16/24/16 0.48 -17.24%
15/24/15 0.58 +34.88%
14/24/14 0.43 +4.88%
13/24/13 0.41 +5.13%

Real-time BOERSE MUENCHEN

Last update May 18, 2024 at 01:11 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD31TJ
ISINDE000HD31TJ0
Date issued 26/02/2024
Strike 320 $
Maturity 15/01/2025 (243 Days)
Parity 10 : 1
Emission price 0.59
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.72
Lowest since issue 0.009
Delta0.19x
Omega 7.112
Premium41.52x
Gearing36.56x
Moneyness 0.7205
Difference Strike 89.43 $
Difference Strike %+27.95%
Spread 0.02
Spread %3.39%
Theoretical value 0.5800
Implied Volatility 35.42 %
Total Loss Probability 87.50 %
Intrinsic value 0.000000
Present value 0.5800
Break even 326.31 €
Theta-0.03x
Vega0.05x
Rho0.02x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230.6 USD
Average target price
285.9 USD
Spread / Average Target
+24.01%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW